Vera Therapeutics (VERA) Change in Account Payables (2020 - 2026)
Vera Therapeutics posted quarterly Change in Account Payables of -$8.0 million for Q1 2026, down 598.81% year-on-year from $1.6 million in Q1 2025, and down 319.75% on a QoQ basis from $3.6 million in Q4 2025.
Vera Therapeutics (VERA) has 7 years of Change in Account Payables data on file, last reported at -$8.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 598.81% year-over-year to -$8.0 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 7.25% YoY), and the FY2025 full-year result was $13.9 million, up 502.84% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$8.0 million, down from $3.6 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $8.0 million in Q2 2023 and bottomed at -$8.0 million in Q1 2026.
- The 5-year median for Change in Account Payables is -$62000.0 (2024), against an average of $719058.8.
- The widest annual swing landed in 2023, when Change in Account Payables slumped 1261.11%; it then soared 7830.65% in 2025.
- A 5-year view of Change in Account Payables shows it stood at $5.0 million in 2022, then slumped by 123.74% to -$1.2 million in 2023, then jumped by 359.14% to $3.1 million in 2024, then advanced by 18.35% to $3.6 million in 2025, then slumped by 319.75% to -$8.0 million in 2026.
- The last three Change in Account Payables figures came in at -$8.0 million (Q1 2026), $3.6 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Vera Therapeutics | 2.43 Bn | 1.83 Bn | - | -7.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.97 Mn |
| Mar 31, 2026 | -7.97 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Dec 31, 2025 | 3.63 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Sep 30, 2025 | 4.79 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Mar 31, 2025 | 1.60 Mn |
| Dec 31, 2024 | 3.06 Mn |
| Dec 31, 2024 | 3.06 Mn |
| Sep 30, 2024 | -62,000.00 |
| Sep 30, 2024 | -62,000.00 |
| Jun 30, 2024 | -545,000.00 |
| Jun 30, 2024 | -545,000.00 |
| Mar 31, 2024 | -5.91 Mn |
| Mar 31, 2024 | -5.91 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Dec 31, 2023 | -1.18 Mn |
| Sep 30, 2023 | -980,000.00 |
| Sep 30, 2023 | -980,000.00 |
| Jun 30, 2023 | 7.95 Mn |
| Jun 30, 2023 | 7.95 Mn |
| Mar 31, 2023 | -6.67 Mn |
| Mar 31, 2023 | -6.67 Mn |
| Dec 31, 2022 | 4.98 Mn |
| Dec 31, 2022 | 4.98 Mn |
| Sep 30, 2022 | -72,000.00 |
| Sep 30, 2022 | -72,000.00 |
| Jun 30, 2022 | -244,000.00 |
| Jun 30, 2022 | -244,000.00 |
| Mar 31, 2022 | 5.94 Mn |
| Mar 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 420,000.00 |
| Dec 31, 2021 | 420,000.00 |
| Sep 30, 2021 | -759,000.00 |
| Sep 30, 2021 | -759,000.00 |
| Jun 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 1.01 Mn |
| Mar 31, 2021 | -198,000.00 |
| Mar 31, 2021 | -198,000.00 |
| Dec 31, 2020 | 570,000.00 |
| Dec 31, 2020 | 570,000.00 |
| Sep 30, 2020 | -389,000.00 |
| Sep 30, 2020 | -389,000.00 |
| Jun 30, 2020 | 383,000.00 |
| Jun 30, 2020 | 383,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |